SK Biopharmaceuticals is a Seongnam, South Korea-based biopharmaceutical company and corporate strategic investor relevant to life sciences founders. Its investment activity includes later-stage venture exposure in China, with sector relevance across biotechnology, pharmaceuticals, life sciences and oncology. The firm is best suited for biotech and therapeutic companies seeking strategic corporate capital rather than a conventional venture fund.